Glioblastoma treatment guidelines: Consensus by the Spanish Society of Neurosurgery Tumor Section.

Neurocirugía
Sonia Tejada SolísSara Duque

Abstract

Glioblastoma (GBM) treatment starts in most patients with surgery, either resection surgery or biopsy, to reach a histology diagnose. Multidisciplinar team, including specialists in brain tumors diagnose and treatment, must make an individualize assessment to get the maximum benefit of the available treatments. Experts in each GBM treatment field have briefly described it based in their experience and the reviewed of the literature. Each area has been summarized and the consensus of the brain tumor group has been included at the end. GBM are aggressive tumors with a dismal prognosis, however accurate treatments can improve overall survival and quality of life. Neurosurgeons must know treatment options, indications and risks to participate actively in the decision making and to offer the best surgical treatment in every case.

References

Jan 25, 2003·Acta neurochirurgica·V VuorinenJ Jääskeläinen
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W RoaP Forsyth
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Feb 17, 2006·Acta neurochirurgica·M WestphalUNKNOWN Executive Committee of the Gliadel Study Group
Oct 31, 2007·International Journal of Radiation Oncology, Biology, Physics·Stephanie E CombsDaniela Schulz-Ertner
May 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alba A BrandesMario Ermani
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry S FriedmanTimothy Cloughesy
Oct 14, 2009·American Journal of Clinical Oncology·Randall J KimpleDavid E Morris
Feb 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfgang WickRoger Stupp
Jul 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John K ParkPeter McL Black
Aug 11, 2010·Annals of Surgical Oncology·Kaisorn L ChaichanaAlfredo Quiñones-Hinojosa
Mar 23, 2011·Journal of Neurosurgery·Nader SanaiMitchel S Berger
Apr 25, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip C De Witt HamerMitchel S Berger
May 15, 2012·The Lancet Oncology·Wolfgang WickUNKNOWN NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society
Jun 23, 2012·Cancer Treatment Reviews·Normand LaperriereMartin J van den Bent
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark R GilbertMinesh P Mehta
Feb 21, 2014·The New England Journal of Medicine·Mark R GilbertMinesh P Mehta
Feb 21, 2014·The New England Journal of Medicine·Olivier L ChinotTimothy Cloughesy
Apr 24, 2014·Journal of Neuro-oncology·Timothy Charles RykenUNKNOWN AANS/CNS Joint Guidelines Committee
Jun 20, 2015·Acta Neuropathologica·David E ReussAndreas von Deimling
Jul 22, 2015·Neurocirugía·Cristian de Quintana-SchmidtJoan Molet-Teixidó
Mar 8, 2017·Journal of Cellular Physiology·Maryam Moradi BinabajAmir Avan
Mar 16, 2017·The New England Journal of Medicine·James R PerryUNKNOWN Trial Investigators
May 10, 2017·The Lancet Oncology·Michael WellerUNKNOWN European Association for Neuro-Oncology (EANO) Task Force on Gliomas
Jul 5, 2017·Virchows Archiv : an International Journal of Pathology·Sean P FerrisArie Perry
Jul 8, 2017·Journal of Neuro-oncology·Al-Wala AwadMark A Mahan

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Zhonghua wai ke za zhi [Chinese journal of surgery]
H H Jiang, S Lin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Brian M Alexander, Timothy F Cloughesy
Journal of Controlled Release : Official Journal of the Controlled Release Society
C BastiancichF Danhier
© 2021 Meta ULC. All rights reserved